NCT06044519CompletedPhase 4

A Single Centre Randomized Control Trial of Donor Site Wound Dressing After Split Thickness Skin Grafting

Dow University of Health Sciences1 site in 1 country90 target enrollmentStarted: August 1, 2022Last updated: September 21, 2023

Conditions

Interventions

Trial Snapshot

Phase: Phase 4
Status: Completed
Sponsor: Dow University of Health Sciences
Enrollment: 90
Locations: 1
Primary Endpoint: to asses the effective of dressings by measuring itching , pain and scarring

Study Overview Study Design Eligibility Criteria Arms & Interventions Outcomes Investigators Sites Records & Identifiers Similar Trials

Study Overview

Brief Summary

The goal of this clinical trial] is to compare different types of dressings used and there outcomes on STSG donor site wound. The main question[s] it aims to answer are:

the effectiveness of different donor site dressings and their adverse outcomes
the satisfaction of patients with the donor site dressing will be observed. Participants will randomly allocated different types of dressings for split thickness skin graft donor site wound which include alginate hydrocolloid hydrofiber silicon film guaze

Study Design

Study Type: Interventional
Allocation: Randomized
Intervention Model: Parallel
Primary Purpose: Screening
Masking: Single (Participant)

Eligibility Criteria

Ages: 18 Years to — (Adult, Older Adult)
Sex: All
Accepts Healthy Volunteers: Yes

Inclusion Criteria

•. Patients of aged 18 years and above of either gender underwent single donor-site wounds after split-skin grafting and surface area larger than 10 cm2 were included in the study

Exclusion Criteria

•Patients on chemotherapy or corticosteroids were excluded from the study. Non-probability consecutive sampling was employed